Table of Contents Author Guidelines Submit a Manuscript
International Journal of Cell Biology
Volume 2013 (2013), Article ID 973584, 8 pages
http://dx.doi.org/10.1155/2013/973584
Review Article

Clinical Significance of HER-2 Splice Variants in Breast Cancer Progression and Drug Resistance

1Institute of Cellular Medicine, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, UK
2Queen Elizabeth Hospital, Gateshead, Tyne and Wear NE9 6SX, UK

Received 6 June 2013; Accepted 13 June 2013

Academic Editor: Claudia Ghigna

Copyright © 2013 Claire Jackson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [20 citations]

The following is the list of published articles that have cited the current article.

  • Mostafa Ghorab, Marwa El-Gazzar, and Mansour Alsaid, “Synthesis and Anti-Breast Cancer Evaluation of Novel N-(Guanidinyl)benzenesulfonamides,” International Journal of Molecular Sciences, vol. 15, no. 4, pp. 5582–5595, 2014. View at Publisher · View at Google Scholar
  • A. Dittrich, H. Gautrey, D. Browell, and A. Tyson-Capper, “The HER2 Signaling Network in Breast Cancer—Like a Spider in its Web,” Journal of Mammary Gland Biology and Neoplasia, 2014. View at Publisher · View at Google Scholar
  • Lorenzo Castagnoli, Manuela Iezzi, Gaia C. Ghedini, Valentina Ciravolo, Giulia Marzano, Alessia Lamolinara, Roberta Zappasodi, Patrizia Gasparini, Manuela Campiglio, Augusto Amici, Claudia Chiodoni, Arianna Palladini, Pier Luigi Lollini, Tiziana Triulzi, Sylvie Menard, Patrizia Nanni, Elda Tagliabue, and Serenella M. Pupa, “Activated d16HER2 Homodimers and SRC Kinase Mediate Optimal Efficacy for Trastuzumab,” Cancer Research, vol. 74, no. 21, pp. 6248–6259, 2014. View at Publisher · View at Google Scholar
  • Hannah Gautrey, Claire Jackson, Anna-Lena Dittrich, David Browell, Thomas Lennard, and Alison Tyson-Capper, “ SRSF3 and hnRNP H1 regulate a splicing hotspot of HER2 in breast cancer cells ,” RNA Biology, pp. 1–13, 2015. View at Publisher · View at Google Scholar
  • Zijia Sun, Yaqin Shi, Yan Shen, Lulu Cao, Wenwen Zhang, and Xiaoxiang Guan, “Analysis of different HER-2 mutations in breast cancer progression and drug resistance,” Journal of Cellular and Molecular Medicine, 2015. View at Publisher · View at Google Scholar
  • Valentina Gatta, Biljana Petrovic, and Gabriella Campadelli-Fiume, “The Engineering of a Novel Ligand in gH Confers to HSV an Expanded Tropism Independent of gD Activation by Its Receptors,” Plos Pathogens, vol. 11, no. 5, 2015. View at Publisher · View at Google Scholar
  • M. Silipo, H. Gautrey, and A. Tyson-Capper, “Deregulation of splicing factors and breast cancer development,” Journal of Molecular Cell Biology, 2015. View at Publisher · View at Google Scholar
  • G. M. Seigel, S. Sharma, A. S. Hackam, and Dhaval K. Shah, “HER2/ERBB2 immunoreactivity in human retinoblastoma,” Tumor Biology, 2015. View at Publisher · View at Google Scholar
  • Otilia Menyhart, Libero Santarpia, and Balazs Gyorffy, “A Comprehensive Outline of Trastuzumab Resistance Biomarkers in HER2 Overexpressing Breast Cancer,” Current Cancer Drug Targets, vol. 15, no. 8, pp. 665–683, 2015. View at Publisher · View at Google Scholar
  • Maxwell Omabe, Shahid Ahmed, Amer Sami, Yufeng Xie, Min Tao, and Jim Xiang, “HER2-Specific Vaccines for HER2-Positive Breast Cancer Immunotherapy,” World Journal of Vaccines, vol. 05, no. 02, pp. 106–128, 2015. View at Publisher · View at Google Scholar
  • L Castagnoli, G C Ghedini, A Koschorke, T Triulzi, M Dugo, P Gasparini, P Casalini, A Palladini, M Iezzi, A Lamolinara, P L Lollini, P Nanni, C Chiodoni, E Tagliabue, and S M Pupa, “Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer,” Oncogene, 2016. View at Publisher · View at Google Scholar
  • Ekaterina A. Kotelnikova, Anna Paleeva, Olga Kremenetskaya, Mikhail Pyatnitskiy, and Dmitriy Vinogradov, “Practical aspects of NGS-based pathways analysis for personalized cancer science and medicine,” Oncotarget, vol. 7, no. 32, pp. 52493–52516, 2016. View at Publisher · View at Google Scholar
  • Jeffrey S. Ross, Laurie M. Gay, Kai Wang, Siraj M. Ali, Saranya Chumsri, Julia A. Elvin, Ron Bose, Jo-Anne Vergilio, James Suh, Roman Yelensky, Doron Lipson, Juliann Chmielecki, Stanley Waintraub, Brian Leyland-Jones, Vincent A. Miller, and Philip J. Stephens, “ Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies ,” Cancer, 2016. View at Publisher · View at Google Scholar
  • Gabriella Campadelli-Fiume, Biljana Petrovic, Valerio Leoni, Tatiana Gianni, Elisa Avitabile, Costanza Casiraghi, and Valentina Gatta, “Retargeting Strategies for Oncolytic Herpes Simplex Viruses,” Viruses, vol. 8, no. 3, pp. 63, 2016. View at Publisher · View at Google Scholar
  • Marco Silipo, Hannah Gautrey, Swapna Satam, Thomas Lennard, and Alison Tyson-Capper, “ How is Herstatin, a tumour suppressor splice variant of the oncogene HER2, regulated? ,” RNA Biology, pp. 00–00, 2016. View at Publisher · View at Google Scholar
  • Soroku Yagihashi, Ryuichi Wada, and Zenya Naito, “mRNA expression of delta-HER2 and its clinicopathological correlation in HER2-overexpressing breast cancer,” Molecular Medicine Reports, vol. 14, no. 6, pp. 5104–5110, 2016. View at Publisher · View at Google Scholar
  • Vladimir N. Uversky, “(Intrinsically disordered) splice variants in the proteome: implications for novel drug discovery,” Genes & Genomics, 2016. View at Publisher · View at Google Scholar
  • Shiva Seyed Forootan, Joe M. Butler, Derek Gardener, Alison E. Baird, Andrew Dodson, Alistair Darby, John Kenny, Neil Hall, Andrew R. Cossins, Christopher S. Foster, and Christine M. Gosden, “Transcriptome sequencing of human breast cancer reveals aberrant intronic transcription in amplicons and dysregulation of alternative splicing with ma,” International Journal Of Oncology, vol. 48, no. 1, pp. 130–144, 2016. View at Publisher · View at Google Scholar
  • Biljana Petrovic, Tatiana Gianni, Valentina Gatta, and Gabriella Campadelli-Fiume, “Insertion of a ligand to HER2 in gB retargets HSV tropism and obviates the need for activation of the other entry glycoproteins,” PLOS Pathogens, vol. 13, no. 4, pp. e1006352, 2017. View at Publisher · View at Google Scholar
  • Arianna Palladini, Claudio Ceccarelli, Donatella Santini, Enrico Di Oto, Sofia Asioli, Augusto Amici, Serenella M. Pupa, Carla De Giovanni, Giordano Nicoletti, Pier-Luigi Lollini, Alessia Lamolinara, Massimiliano Dall'Ora, Tania Balboni, Veronica Giusti, Mario Taffurelli, Elda Tagliabue, Manuela Iezzi, Patrizia Nanni, Marianna L. Ianzano, Roberta Laranga, and Lorena Landuzzi, “HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic response,” Oncotarget, vol. 8, no. 33, pp. 54444–54458, 2017. View at Publisher · View at Google Scholar